Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis
18 Years
N/A
Both
Cutaneous T Cell Lymphoma, Graft Versus Host Disease
Trial Information
Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis
The investigators intend to report outcomes from the inception of this procedure at
Dartmouth-Hitchcock Medical Center (DHMC) in May 2008 through 9/30/11. Additionally, the
investigators would like to maintain a prospective database of these patients so that new
patient data can be collected for updating of outcomes.
Inclusion Criteria:
- Patients who receive Extracorporeal Photopheresis treatment
- Treated at Dartmouth-Hitchcock Medical Center
- Must be 18 years or older
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Response rates
Outcome Description:
Response rates to ECP treatment
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Frederick Lansigan, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Dartmouth-Hitchcock Medical Center
Authority:
United States: Institutional Review Board
Study ID:
D11271
NCT ID:
NCT01460914
Start Date:
October 2011
Completion Date:
October 2050
Related Keywords:
- Cutaneous T Cell Lymphoma
- Graft Versus Host Disease
- ECP
- CTCL
- Extracorporeal photopheresis
- Cutaneous T Cell Lymphoma
- GVHD
- Graft versus host disease
- Graft vs Host Disease
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
Name | Location |
|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire 03756 |
